Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended December 31, 2016
IOL Chemicals & Pharmaceuticals Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended December 31, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Shareholding for the Period Ended December 31, 2016
IOL Chemicals & Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2016. For more details, kindly Click here Credit Rating
IOL Chemicals & Pharmaceuticals Ltd has informed BSE that Credit Analysis & Research Ltd (CARE) has revised the credit rating for Long term Bank Facilities to CARE BB; Stable (Double B; Outlook: Stable) from 'CARE BB-' (Double B Minus) and reaffirmed the credit rating for Short term Bank Facilities to 'CARE A4' (A Four). National Energy Conservation Award - 2016
IOL Chemicals & Pharmaceuticals Ltd has informed BSE that the Company has won the National Energy Conservation Award - 2016. The Company has awarded with the Second prize in Chemical Sector for its continued efforts towards new technology implementation so as to conserve energy resources of the country. Mr Vijay Singla, Director (Works) received the award from Sh. Pyush Goyal - The Hon'ble Minister of State (l/C) for Power, Coal, New & Renewable... Standalone Financial Results, Limited Review Report, Results Press Release for September 30, 2016
IOL Chemicals & Pharmaceuticals Ltd has informed BSE about : 1. Standalone Financial Results for the period ended September 30, 20162. Standalone Limited Review for the period ended September 30, 20163. Result Press Release for the period ended September 30, 2016 Management Meet
IOL Chemicals & Pharmaceuticals Ltd has submitted to BSE a copy of Management Meet. Board Meeting Intimation for Results & Closure of Trading Window
IOL Chemicals & Pharmaceuticals Ltd has informed BSE that the meeting of the Board of Directors is scheduled to be held on November 07, 2016, inter alia, to consider and approve the un-audited financial results of the Company for the quarter and half year ended September 30, 2016.Further, in terms of provisions of the Company's Code of Conduct to Regulate, Monitor and Report Trading by Insiders, the "Trading Window" of the Company shall remain... Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended September 30, 2016
IOL Chemicals & Pharmaceuticals Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended September 30, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
Vasudeva Commercials Ltd has submitted the disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 Shareholding for the Period Ended September 30, 2016
IOL Chemicals & Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2016. For more details, kindly Click here